{"id":174450,"name":"PROLACTA BIOSCIENCE, INC.","slug":"prolacta-bioscience-inc","state":"CA","country":"United States of America","description":"Standardized human milk-based nutritional products for premature infants in the NICU","totalSpending":2380000,"filings":33,"yearlySpending":[{"year":2018,"income":400000},{"year":2019,"income":320000},{"year":2020,"income":320000},{"year":2021,"income":300000},{"year":2022,"income":320000},{"year":2023,"income":240000},{"year":2024,"income":240000},{"year":2025,"income":240000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"FOO","display":"Food Industry (safety, labeling, etc.)"},{"code":"BUD","display":"Budget/Appropriations"}],"firms":["TREMONT STRATEGIES GROUP LLC (F/K/A ADS VENTURES)"],"lobbyists":["LIESL GREBENSTEIN SHEEHAN","DAVID GARRIEPY","MALIA CHING"],"govEntities":["Food & Drug Administration (FDA)","HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["LHHS Appropriations, FDA appropriations","LHHS Appropriations, FDA appropriations","LHHS Appropriations, FDA appropriations","LHHS Appropriations, FDA appropriations","LHHS Appropriations, FDA appropriations"]}